Simvastatin is effective in killing the radioresistant breast carcinoma cells. Radiol Oncol [Internet]. 2021 Jul. 28 [cited 2026 Oct. 22];55(3):305-16. Available from: https://www.radioloncol.com/index.php/ro/article/view/3679